Technical Analysis for OBLN - Obalon Therapeutics, Inc.
|Grade||Last Price||% Change||Price Change|
OBLN closed up 3.01 percent on Friday, January 18, 2019, on 28 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.
|See historical OBLN trend table...|
|Date||Alert Name||Type||% Chg|
|Jan 18||Stochastic Buy Signal||Bullish||0.00%|
|Jan 18||Narrow Range Bar||Range Contraction||0.00%|
|Jan 18||Wide Bands||Range Expansion||0.00%|
|Jan 18||Oversold Stochastic||Weakness||0.00%|
|Jan 17||Spinning Top||Other||3.01%|
|Jan 17||Wide Bands||Range Expansion||3.01%|
|Jan 17||Down 3 Days in a Row||Weakness||3.01%|
|Jan 17||Oversold Stochastic||Weakness||3.01%|
|Jan 16||Narrow Range Bar||Range Contraction||0.59%|
|Jan 16||Doji - Bullish?||Reversal||0.59%|
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicatorsBasic chart:
Obalon Therapeutics, Inc. is a commercial-stage medical device company focused on developing and commercializing medical devices to treat obese and overweight people by facilitating weight loss. The Company's product, Obalon balloon system, is a swallowable, gas-filled intragastric balloon designed to provide weight loss in obese patients. The Obalon balloon system is intended to be used as an adjunct to a moderate intensity diet and behavior modification program. All balloons must be removed six months after the first balloon is placed. The Obalon balloon system intends to provide patients and physicians with a reversible and repeatable weight loss solution in an outpatient setting, without altering patient anatomy or requiring surgery. The Company has received Premarket approval (PMA) for its Obalon balloon system based on the results of its United States pivotal clinical trial, referred to as the SMART trial.
|Indicator||Bull Case||Neutral / Hold||Bear Case|
|Oversold / Overbought|
|Summary:||Counts: 2 bullish, 3 bearish and 0 neutral indicators. You may wish to incorporate that into your trading strategies.|
See more OBLN news...
|52 Week High||5.7|
|52 Week Low||1.46|
|200-Day Moving Average||2.3953|
|50-Day Moving Average||1.9121|
|20-Day Moving Average||2.0185|
|10-Day Moving Average||1.771|
|Average True Range||0.2306|
|Chandelier Exit (Long, 3 ATRs )||2.7082|
|Chandelier Exit (Short, 3 ATRs )||2.1918|
|Upper Bollinger Band||2.7259|
|Lower Bollinger Band||1.3111|
|Percent B (%b)||0.28|
|MACD Signal Line||-0.0325|
|Market Cap||28.77 Million|
|Num Shares||16.8 Million|
|Price-to-Earnings (P/E) Ratio||-0.74|
|Pivot Point Level||Traditional / Classic||Fibonacci||Demark||Woodie||Camarilla|
|Resistance 4 (R4)||1.86|
|Resistance 3 (R3)||1.86||1.81||1.84|
|Resistance 2 (R2)||1.81||1.77||1.81||1.83|
|Resistance 1 (R1)||1.76||1.75||1.79||1.76||1.82|
|Support 1 (S1)||1.66||1.67||1.69||1.66||1.60|
|Support 2 (S2)||1.61||1.65||1.61||1.59|
|Support 3 (S3)||1.56||1.61||1.59|
|Support 4 (S4)||1.56|